Jack Nathan Medical Corp.
JNHMF
$0.026
-$0.0031-10.65%
| Weiss Ratings | JNHMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | JNHMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | JNHMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.48 | |||
| Price History | JNHMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -10.65% | |||
| 60-Day Total Return | 13.04% | |||
| 90-Day Total Return | -20.97% | |||
| Year to Date Total Return | 192.13% | |||
| 1-Year Total Return | -49.12% | |||
| 2-Year Total Return | -64.38% | |||
| 3-Year Total Return | -83.09% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -57.65% | |||
| 52-Week Low % Change | 192.13% | |||
| Price | JNHMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.06 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Dec 30, 2024 | |||
| 52-Week High Price (Date) | Dec 24, 2024 | |||
| Valuation | JNHMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.51M | |||
| Enterprise Value | 10.88M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.07 | |||
| Earnings Per Share Growth | 0.29% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.16 | |||
| Price/Book (Q) | -0.26 | |||
| Enterprise Value/Revenue (TTM) | 0.70 | |||
| Price | $0.03 | |||
| Enterprise Value/EBITDA (TTM) | -2.47 | |||
| Enterprise Value/EBIT | -2.12 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | JNHMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 96.10M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | JNHMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416 637 2240 | |||
| Address | 6-6150 Highway 7 Woodbridge, ON L4H 0R6 | |||
| Website | www.jacknathanhealth.com | |||
| Country | Canada | |||
| Year Founded | 2006 | |||
| Profitability | JNHMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -33.14% | |||
| Profit Margin | -38.88% | |||
| Management Effectiveness | JNHMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -48.66% | |||
| Return on Equity | -- | |||
| Income Statement | JNHMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 15.68M | |||
| Total Revenue (TTM) | 15.68M | |||
| Revenue Per Share | $0.16 | |||
| Gross Profit (TTM) | 12.22M | |||
| EBITDA (TTM) | -4.47M | |||
| EBIT (TTM) | -5.20M | |||
| Net Income (TTM) | -6.10M | |||
| Net Income Avl. to Common (TTM) | -6.10M | |||
| Total Revenue Growth (Q YOY) | 5.69% | |||
| Earnings Growth (Q YOY) | 13.04% | |||
| EPS Diluted (TTM) | -0.07 | |||
| EPS Diluted Growth (Q YOY) | 14.69% | |||
| Balance Sheet | JNHMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 262.10K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 1.75M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -8.64M | |||
| Current Ratio (Q) | 0.349 | |||
| Book Value Per Share (Q) | -$0.10 | |||
| Total Assets (Q) | 4.78M | |||
| Total Current Liabilities (Q) | 5.02M | |||
| Total Debt (Q) | 9.95M | |||
| Total Liabilities (Q) | 13.42M | |||
| Total Common Equity (Q) | -8.64M | |||
| Cash Flow | JNHMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.52M | |||
| Cash from Financing (TTM) | 2.96M | |||
| Net Change in Cash (TTM) | -3.63M | |||
| Levered Free Cash Flow (TTM) | -4.99M | |||
| Cash from Operations (TTM) | -5.12M | |||
